Several studies have confirmed that the Fas/FasL system is important for T­cell apoptosis in inflammatory and immune diseases [28–30], and enhancement of Fas/FasL expression is a promising strategy to improve MSC cytotherapy at the molecular level [31]. This evidence concerns the gene FASLG and immune system disorder.